Supplementary protection
LT - Kietos 3-(6-(1-(2,2-difluorbenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzoinės rūgšties formos
EN - SOLID FORMS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID
SPC
| (11) |
Number of the document |
C 3170818 |
| (68) |
Number of the document |
3170818
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2020 525 |
| (22) |
Date of filing the application |
2020-08-14 |
| (41) |
Date of publication of the application |
2020-09-10 |
|
Date of publication of SPC |
2023-05-25 |
| (24) |
Date of coming into effect of SPC |
2028-12-05 |
Applicant
| (71) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
Grantee
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/15/1059, 2015-11-19
|
Calculated date of expiry of the SPC
| (94) |
2030-11-24 |
Name of the product protected by the basic patent
| (95) |
(a) 3-(6-(1-(2,2-difluorbenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzenkarboksirūgšties ir (b) N-(5-hidroksi-2,4-ditert-butilfenil)-4-okso-1H-chinolin-3-karboksamido arba farmaciniu požiūriu priimtinos N-(5-hidroksi-2,4-ditert-butil-fenil)-4-okso-1H-chinolin-3-karboksamido druskos derinys |
